With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...

She brings her global experience across multiple therapeutic areas to her current role leading operations at YPrime. In this ...

She brings her global experience across multiple therapeutic areas to her current role leading operations at YPrime. In this ...

MinervaX and Wacker Biotech announced yesterday that they have entered into a manufacturing agreement for MinervaX’s ...

The original concerns of the US regulatory agency over the manufacturing of Eli Lilly’s Ebglyss seem to have been resolved, ...

The FDA has granted Orphan Drug and Rare Pediatric Disease Designations to Somite’s cell replacement therapy for the ...

Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have ...

The San Diego-based biotech company Candid Therapeutics has launched with a huge $370 million with the aim to develop T-cell ...

Emmanuelle Cameau is strategic technology partnership leader at Cytiva. Read our interview to discover how losing her beloved ...

The European Commission has granted Orphan Drug Designation for Vivet Therapeutics’ gene therapy product VTX-806 for the ...

Adaptin Bio has announced that the FDA has given the green light to start phase 1 clinical trials for its program APTN-101 ...

New data from the QWINT clinical trial may get Eli Lilly closer to bringing a once-weekly insulin injection to the US, ...